Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history

Abstract Background SOD1 mutations are the most common cause of amyotrophic lateral sclerosis (ALS) in non-Caucasian patients. Detailed natural history profiles of SOD1-mutant patients will be beneficial for the strategy and interpretation of future SOD1-targeted clinical practice. Methods Mutationa...

Full description

Bibliographic Details
Main Authors: Lu Tang, Yan Ma, Xiao-lu Liu, Lu Chen, Dong-sheng Fan
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Translational Neurodegeneration
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40035-018-0142-8
_version_ 1818902448801054720
author Lu Tang
Yan Ma
Xiao-lu Liu
Lu Chen
Dong-sheng Fan
author_facet Lu Tang
Yan Ma
Xiao-lu Liu
Lu Chen
Dong-sheng Fan
author_sort Lu Tang
collection DOAJ
description Abstract Background SOD1 mutations are the most common cause of amyotrophic lateral sclerosis (ALS) in non-Caucasian patients. Detailed natural history profiles of SOD1-mutant patients will be beneficial for the strategy and interpretation of future SOD1-targeted clinical practice. Methods Mutational distribution, age at onset (AAO), site of onset, diagnostic delay, disease progression (rate of ALSFRS-R decrease, ΔFS) and survival were analysed. Further comparisons between heredity of disease, gender, and mutations were performed. Results Sixty-six cases with 43 SOD1 mutations were included and analysed, with p.His47Arg as the leading mutation and seven novel variants identified. The mean (SD) AAO was 43.92 years (9.24) for all subjects, with a significant difference between patients carrying mutations in exon 2 (n = 24,46.83, 8.31) and exon 4 (n = 18, 37.75, 7.67) (p = 0.002). The median (IQR) diagnostic delay from symptom onset was 14.50 (6.00–36.50) months for all SOD1-mutant patients, 9.50 (4.75–24.25) months for males and 24.00 (9.50–47.50) months for females, revealing a gender difference (p = 0.009). Similar advantages in median (IQR) ΔFS [male: female, 0.55 (0.24–0.94) vs 0.19 (0.06–0.90), p = 0.041] and mean (95% CI) survival [57.4 (38.90–75.90) months vs 125.6 (99.80–151.50) months, p = 0.006] were also observed in females, both of which existed in sporadic ALS only when stratified by familiar or sporadic ALS. Conclusions The results highlight a distinct mutational distribution and natural history spectrum in ALS patients carrying SOD1 mutations in China. A prominent mild disease progression was observed in female patients, which had rarely been reported in the previous literature. This finding, together with the detailed analysis of natural history among each mutation, can have important implications for future genetic counselling and SOD1-targeted clinical trials.
first_indexed 2024-12-19T20:35:49Z
format Article
id doaj.art-759feff7ed27464fa9e8a4fa794709fb
institution Directory Open Access Journal
issn 2047-9158
language English
last_indexed 2024-12-19T20:35:49Z
publishDate 2019-01-01
publisher BMC
record_format Article
series Translational Neurodegeneration
spelling doaj.art-759feff7ed27464fa9e8a4fa794709fb2022-12-21T20:06:33ZengBMCTranslational Neurodegeneration2047-91582019-01-018111010.1186/s40035-018-0142-8Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural historyLu Tang0Yan Ma1Xiao-lu Liu2Lu Chen3Dong-sheng Fan4Department of Neurology, Peking University Third HospitalDepartment of Neurology, Peking University Third HospitalDepartment of Neurology, Peking University Third HospitalDepartment of Neurology, Peking University Third HospitalDepartment of Neurology, Peking University Third HospitalAbstract Background SOD1 mutations are the most common cause of amyotrophic lateral sclerosis (ALS) in non-Caucasian patients. Detailed natural history profiles of SOD1-mutant patients will be beneficial for the strategy and interpretation of future SOD1-targeted clinical practice. Methods Mutational distribution, age at onset (AAO), site of onset, diagnostic delay, disease progression (rate of ALSFRS-R decrease, ΔFS) and survival were analysed. Further comparisons between heredity of disease, gender, and mutations were performed. Results Sixty-six cases with 43 SOD1 mutations were included and analysed, with p.His47Arg as the leading mutation and seven novel variants identified. The mean (SD) AAO was 43.92 years (9.24) for all subjects, with a significant difference between patients carrying mutations in exon 2 (n = 24,46.83, 8.31) and exon 4 (n = 18, 37.75, 7.67) (p = 0.002). The median (IQR) diagnostic delay from symptom onset was 14.50 (6.00–36.50) months for all SOD1-mutant patients, 9.50 (4.75–24.25) months for males and 24.00 (9.50–47.50) months for females, revealing a gender difference (p = 0.009). Similar advantages in median (IQR) ΔFS [male: female, 0.55 (0.24–0.94) vs 0.19 (0.06–0.90), p = 0.041] and mean (95% CI) survival [57.4 (38.90–75.90) months vs 125.6 (99.80–151.50) months, p = 0.006] were also observed in females, both of which existed in sporadic ALS only when stratified by familiar or sporadic ALS. Conclusions The results highlight a distinct mutational distribution and natural history spectrum in ALS patients carrying SOD1 mutations in China. A prominent mild disease progression was observed in female patients, which had rarely been reported in the previous literature. This finding, together with the detailed analysis of natural history among each mutation, can have important implications for future genetic counselling and SOD1-targeted clinical trials.http://link.springer.com/article/10.1186/s40035-018-0142-8Amyotrophic lateral sclerosisNatural history studiesSOD1 mutationsGender difference
spellingShingle Lu Tang
Yan Ma
Xiao-lu Liu
Lu Chen
Dong-sheng Fan
Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
Translational Neurodegeneration
Amyotrophic lateral sclerosis
Natural history studies
SOD1 mutations
Gender difference
title Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
title_full Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
title_fullStr Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
title_full_unstemmed Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
title_short Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history
title_sort better survival in female sod1 mutant patients with als a study of sod1 related natural history
topic Amyotrophic lateral sclerosis
Natural history studies
SOD1 mutations
Gender difference
url http://link.springer.com/article/10.1186/s40035-018-0142-8
work_keys_str_mv AT lutang bettersurvivalinfemalesod1mutantpatientswithalsastudyofsod1relatednaturalhistory
AT yanma bettersurvivalinfemalesod1mutantpatientswithalsastudyofsod1relatednaturalhistory
AT xiaoluliu bettersurvivalinfemalesod1mutantpatientswithalsastudyofsod1relatednaturalhistory
AT luchen bettersurvivalinfemalesod1mutantpatientswithalsastudyofsod1relatednaturalhistory
AT dongshengfan bettersurvivalinfemalesod1mutantpatientswithalsastudyofsod1relatednaturalhistory